Skip to main navigation Skip to search Skip to main content

Gut commensal Bifidobacterium longum confers resistance to Salmonella Typhimurium and Shigella flexneri in a Caenorhabditis elegans model

  • Phurt Harnvoravongchai
  • , Samara Paula Mattiello
  • , Achuthan Amabat
  • , C. P. Jusail
  • , Syed M. Faisal
  • , Radhey S. Kaushik
  • , Joy Scaria
  • Mahidol University
  • Oklahoma State University
  • South Dakota State University
  • University of Tennessee Southern
  • National Institute of Animal Biotechnology

Research output: Contribution to journal › Article › peer-review

2 Citations (Scopus)

Abstract

Salmonellosis and shigellosis remain major global health concerns, with Salmonella Typhimurium and Shigella flexneri classified as high-priority antibiotic-resistant pathogens by the World Health Organization. The development of new antibiotics is slow and challenging, underscoring the need for alternative therapeutic strategies. One promising approach involves leveraging gut microbiota-derived bacteria that confer colonization resistance against enteric pathogens. In this study, we screened a human gut microbiota culture collection and identified Bifidobacterium longum as the most effective species in inhibiting S. Typhimurium and S. flexneri in vitro. To evaluate its protective potential in vivo, we utilized Caenorhabditis elegans as a model system. Our findings demonstrate that B. longum significantly reduced pathogen burden and enhanced host survival following infection. Mechanistic analysis revealed that B. longum inhibits S. Typhimurium primarily through acidification, while S. flexneri suppression appears to involve a protein-mediated or heat-stable metabolite-dependent mechanism. Additionally, B. longum modulated host immune pathways, downregulating genes associated with the p38 MAPK and insulin/IGF-1 signaling pathways. These results highlight the potential of B. longum as a non-antibiotic therapeutic for controlling Salmonella and Shigella infections. However, further validation in mammalian models is required to assess its clinical relevance.

Original languageEnglish
Pages (from-to)1-15
Number of pages15
JournalMicrobiology Spectrum
Volume14
Issue number1
DOIs
Publication statusPublished - 6 Jan 2025
Externally publishedYes

Keywords

  • colonization resistance
  • gut microbiota
  • non-antibiotic therapy

Fingerprint

Dive into the research topics of 'Gut commensal Bifidobacterium longum confers resistance to Salmonella Typhimurium and Shigella flexneri in a Caenorhabditis elegans model'. Together they form a unique fingerprint.

Cite this